Pricey New Blood Thinner Might Be Safer for Leg Clots

In trial, Eliquis worked as well as warfarin but with less risk of bleeding

HealthDay SHARE

Beyond serious bleeding, Weitz said people taking Eliquis also had less nuisance bleeding of the gums or nose, which can lead patients to stop taking their medication.

"I think it's very important," said Weitz, who reported that he has been a consultant for study sponsors Bristol-Myers Squibb and Pfizer, along with other pharmaceutical companies, within the past three years.

Another expert who wasn't involved in the study agreed.

"This new approach may simplify the treatment regimen, improve patient convenience and substantially increase the safety of venous thromboembolism treatment, making this an attractive new option," said Dr. Gregg Fonarow, who is co-director of the University of California, Los Angeles, preventive cardiology program at the David Geffen School of Medicine.

More information

For more on venous thromboembolism, head to the U.S. National Heart, Lung, and Blood Institute.

Copyright © 2012 HealthDay. All rights reserved.